CORANGE LTD

CORANGE LTD

Previous company name

Name change date

Company Overview
The company, with registered office located in Hamilton, Bermuda, is primarily engaged in the research, development, manufacture and sale of Cardiac Thrombolytic Agents and DAT (Drugs of Abuse Testing) reagents in Bermuda and abroad, through its subsidiaries.
The company is one of the leading suppliers of Cardiac Thrombolytic Agents in the United States. In 1998, the company was acquired by the Switzerland-based Roche Group, which is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
Business Summary
Corange Ltd is a diversified international human healthcare company. In diagnostics, therapeutics and orthopaedics, its products and research programmes are world leading.
Description and history
The Company is a diversified international human healthcare company such as in diagnostics, therapeutics and orthopaedics.
The acquisition of Corange Ltd by Roche was completed in 1998.

Business Line
Engaged in the research, development, manufacture and sale of Cardiac Thrombolytic Agents and DAT (Drugs of Abuse Testing) reagents in Bermuda and abroad, through its subsidiaries
Subsidiary

Advisor
PRICE WATERHOUSE
IPO date

US SIC Code
8099
Company Address
P O Box Hm 2026

City province or state postal code
HM HX, HAMILTON
Phone: +1 441 295 8290
Fax: +1 441 292 0964
Country address: BERMUDA
Website url: